Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update

RTTNews | 824 gün önce
Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, medical devices maker Medtronic plc. (MDT) initiated adjusted earnings guidance for the full-year 2024, below analysts' estimates.

For fiscal 2023, the company now projects adjusted earnings in a range of $5.00 to $5.10 per share on organic revenue growth of 4.0 to 4.5 percent.

On average, 30 analysts polled by Thomson Reuters expect the company to report earnings of $5.20 per share for the quarter. Analysts' estimates typically exclude special items.

The Medtronic board of directors also approved an increase in Medtronic's cash dividend for the first quarter of fiscal year 2024, raising the quarterly amount to $0.69 per ordinary share, payable on July 14, 2023, to shareholders of record at the close of business on June 23, 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Etiketler: MDT
read more
FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I

FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I

Medical devices maker Medtronic plc has urged customers to discontinue clinical use of the recently recalled certain Newport branded ventilators and certain related service parts after the U.S. Food and Drug Administration upgraded it to a Class I recall. According to the FDA, a Class I recall is the most serious type of recall, a situation where the use of, or exposure to, a violative product...
RTTNews | 75 gün önce
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Healthcare technology company Medtronic plc (MDT) announced Thursday it filed a complaint with the U.S. International Trade Commission (ITC), along with a parallel action in U.S. District Court for the District of Delaware, to block Axonics, Inc. (AXNX) from improperly importing and selling products that infringe two Medtronic patents related to the MRI compatibility of implantable medical devices.
RTTNews | 544 gün önce
Medtronic Boosts FY24 Outlook - Update

Medtronic Boosts FY24 Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2024, based on third quarter performance.
RTTNews | 553 gün önce
Medtronic Boosts FY23 Adj. EPS Outlook - Update

Medtronic Boosts FY23 Adj. EPS Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) provided its revenue growth guidance for the fourth quarter and raised adjusted earnings outlook for the full-year 2023, based on third quarter performance.
RTTNews | 917 gün önce
Medtronic Reiterates FY23 Outlook - Update

Medtronic Reiterates FY23 Outlook - Update

While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
RTTNews | 1099 gün önce